Clinical Trial Update: Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma [Phase 1, Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 1/2 clinical trial testing an anti-VEGF gene therapy for vestibular schwannoma, with recruitment status listed as recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vestibular Schwannoma

Drugs mentioned

• Anti-VEGF gene therapy

Snippet

Sponsor: Akouos, Inc. | Conditions: Vestibular Schwannoma | Phase 1, Phase 2 | Status: RECRUITING